Unlocking the potential of PSMA as a cancer target
Interviewee/Contributor
Brian McGuinness and Theodora Harold
Organisation
Crescendo Biologics Ltd
Cancer (Oncology)
New cancer drugs have unique mechanisms of action
Interviewee/Contributor
Bruno Pagliara
Organisation
Oncology specialist Bruno Pagliara
Late-stage oncology pipeline is robust
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous
A meeting of minds at AstraZeneca
Interviewee/Contributor
José Baselga
Organisation
AstraZeneca Plc
Groundbreaking genomic study of cancer published
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
The US continues to lead in oncology approvals
Interviewee/Contributor
Bruno Pagliara
Organisation
MedNous
The role of relapse vaccines in fighting cancer
Interviewee/Contributor
Erik Manting
Organisation
DCPrime BV
Oncology Review: New drugs target niche tumours, expand patient benefit
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting
WHO embraces innovation in oncology
Interviewee/Contributor
Victoria English
Organisation
MedNous
ASCO 2019: Successes and setbacks mark the cancer meeting
Interviewee/Contributor
Bruno Pagliara
Organisation
On-kòs Pharma Consulting